Ruling Out Other Conditions Needed With Suspected Interstitial Cystitis
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 4, 2024 -- Efforts to rule out bladder tumors and tuberculosis are still essential in the follow-up of patients with suspected interstitial cystitis (IC), according to a study published online Aug. 11 in the International Journal of Gynecology & Obstetrics.
Hyun Ju Jeong, from the Seoul National University College of Medicine in South Korea, and colleagues reviewed the electronic medical records of 646 consecutive patients with pelvic pain diagnosed with IC between October 2005 and December 2019 to understand the impact of excluding confusable diseases.
The researchers found that 74.6 percent of patients underwent observational cystoscopy under the suspicion of IC; 2.2 percent (14 patients) had genitourinary tract malignancies, including bladder cancer (13 patients) and prostate cancer (one patient). Among individuals with bladder cancer, three patients were diagnosed during initial observation cystoscopy, while the remaining 10 patients were diagnosed during subsequent follow-up cystoscopic surgery. Seven patients overall were diagnosed with urinary tuberculosis (1.1 percent); five of the six patients (0.8 percent) with suspected urinary tuberculosis at baseline imaging were positive for tuberculosis in the acid-fast bacillus test. Tuberculous granulomas in the bladder tissue developed in one patient after a cystectomy for intractable pelvic pain.
"Our results show that continuous efforts to rule out bladder tumors or tuberculosis are still essential in the follow-up of patients with suspected IC, even if these diseases are not excluded at the initial examination," the authors write. "Imaging studies are necessary to rule out tuberculosis."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Read this next
Extended Lymphadenectomy Fails to Improve Survival in Bladder Cancer
THURSDAY, Oct. 3, 2024 -- For patients with muscle-invasive bladder cancer, extended lymphadenectomy does not improve disease-free or overall survival compared with standard...
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
FRIDAY, Sept. 20, 2024 -- Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk muscle-invasive urothelial...
Socioeconomic Disparities Impact Immunotherapy Use in Urologic Cancers
FRIDAY, Sept. 6, 2024 -- Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with advanced clear cell renal cell...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.